Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Germany

 

Apollo buys minority stake in Bayer’s contraceptives business for €3bn

Private equity firm Apollo has spent €3 billion buying an undisclosed but likely substantial minority stake in German multinational pharma company Bayer’s contraceptives business, which sells intrauterine devices (IUDs). This part of the business, which accounts for just 3% of Bayer’s total revenue, will be held in a newly established entity which Bayer will retain full control over. Given Bayer’s current market cap of around €45.8 billion, Apollo’s acquisition amounts to about 6.6% of the company’s total number of shares.
July 16, 2026

Bergman Clinics’ Jeroen Cammeraat on building a scalable multinational outpatient platform

Bergman Clinics is a multinational European clinic chain that focuses on elective medical specialist (secondary) care done in an outpatient setting. In a conversation with HBI Jeroen Cammeraat, CEO, explained how being focused on high volume elective procedures that can be done in an outpatient setting makes it possible to build an efficient and scalable multinational healthcare operator.
July 9, 2026

TPG creates European outpatient real estate platform from €400m worth of MOBs bought from Northwest

Private equity investor TPG has launched a specialist outpatient real estate investment platform to hold the €400 million worth of German and Dutch medical outpatient buildings (MOBs) it bought from Canada-based healthcare REIT Northwest in January, and acquire similar additional properties. The platform, called Arcura Medical Properties, will remain fully owned by TPG’s real estate investment branch (TPG Real Estate), but will operate “independently”, managed by Simon Betty as CEO, who formerly headed Northwest’s European branch, along with his team.
July 7, 2026

Structural tailwinds from hospital reform driving growth in German outpatient intensive care sector- Dr Erik Hamann, Opseo 

Germany’s outpatient intensive care market is entering a period of structural change, creating significant opportunities for providers with scale, according to Dr Erik Hamann, CEO of Opseo, a German provider of intensive care services. HBI recently spoke to Hamann about Germany’s hospital reform, increasing regulatory complexity and ongoing market consolidation. These trends are reshaping the […]
June 16, 2026

Interview with Niklas Kouparanis, founder and CEO of Europe’s largest medical cannabis digital health company, Bloomwell

Germany’s medical cannabis market has been booming since it was removed from the list of controlled narcotic substances in 2024, which made prescribing it much easier. Now as many as one million Germans are being prescribed cannabis, according to the most often cited figure by those in the industry. The majority of these prescriptions are being handed out by digital health companies specialising in cannabis. The largest of these companies is Bloomwell, who HBI sat down with last week at Cannabis Europa (a conference focused on medicinal cannabis).
June 4, 2026

Verdane invests in ETERNO

Oslo-based private equity firm Verdane has invested in Berlin-based healthcare technology company ETERNO to support its expansion in Germany as it scales its AI-native operating system for outpatient care.
May 21, 2026
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us